Earnings · US stocks

Lipocine Inc (LPCN) earnings

Lipocine Inc published its quarterly report on 2026-11-05. The stock moved +19.44% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-05
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+6.25%—
3 days+19.44%—
7 days+18.75%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 4 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +2.95%).

PublishedEPS YoYEPSEPS surprise3 days after30 days after30d vs index
2026-11-05—-0.08+77.46%+19.44%——
2026-08-04—-0.32+20.00%+0.95%+3.55%+3.59%
2026-05-07—-0.54-11.34%-4.53%-4.12%-5.87%
2026-03-10-227.30%-0.42+31.15%+2.16%-70.18%-73.98%
2025-11-06—-0.59-9.26%+12.89%+64.06%+64.23%
2025-08-05—-0.41-2.50%-4.79%-5.75%-10.32%
2025-05-08-153.00%-0.35—-11.52%+0.00%-5.90%
2025-03-13—0.33+182.50%+9.03%-0.93%+1.24%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: LPCN

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.